Literature DB >> 6136536

Enhancement of depolarization-dependent neurosecretion from PC12 cells by forskolin-induced elevation of cyclic AMP.

C S Rabe, J Schneider, R McGee.   

Abstract

The effects of elevated intracellular cyclic AMP on the release of neurotransmitters was studied using the clonal pheochromocytoma cell line, PC12, and forskolin, a direct activator of adenylate cyclase. Intracellular cyclic AMP concentrations ranging from 8 to 400 times basal levels were achieved with 0.1 to 100 uM forskolin. Unstimulated release of neurotransmitters was unchanged by any concentration of forskolin. However, K+-stimulated release of both norepinephrine (NE) and acetylcholine was enhanced by 0.1 to 10 uM forskolin. Release of NE elicited by depolarization with carbachol and veratridine also was enhanced by 1 uM forskolin. Enhancement of release was reversed by higher concentrations of forskolin, especially in the presence of a phosphodiesterase inhibitor (RO 20-1724) which caused very large increases in cyclic AMP content. The enhancement of transmitter release from the PC12 cells occurred without concomitant changes in agonist-stimulated ion flux through the acetylcholine receptor ion channel, or in depolarization-dependent uptake of 45Ca++. Thus, increasing the cyclic AMP content of PC12 cells fails to initiate neurosecretion but appears to facilitate some element in the secretion process subsequent to Ca++ influx.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6136536

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Res        ISSN: 0095-1544


  15 in total

1.  Hypertrophy of pheochromocytoma cells treated with nerve growth factor and activators of adenylate cyclase.

Authors:  A S Tischler; H Mobtaker; P W Kwan; W J Jason; R A DeLellis; H J Wolfe
Journal:  Cell Tissue Res       Date:  1987-07       Impact factor: 5.249

2.  Mutants of PC12 cells with altered cyclic AMP responses.

Authors:  T Block; C Kon; B M Breckenridge
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

3.  Forskolin enhancement of acetylcholine-evoked cyclic AMP formation and catecholamine release in perfused dog adrenals.

Authors:  T Dohi; K Morita; S Kitayama; A Tsujimoto
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

4.  Adenosine 3',5'-cyclic monophosphate-mediated enhancement of calcium-evoked prolactin release from electrically permeabilised 7315c tumour cells.

Authors:  S Guild; E A Frey; S L Pocotte; J W Kebabian
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

5.  Effects of forskolin and analogues on nicotinic receptor-mediated sodium flux, voltage-dependent calcium flux, and voltage-dependent rubidium efflux in pheochromocytoma PC12 cells.

Authors:  Y Nishizawa; K B Seamon; J W Daly; R S Aronstam
Journal:  Cell Mol Neurobiol       Date:  1990-09       Impact factor: 5.046

6.  Second-messenger control of catecholamine release from PC12 cells. Role of muscarinic receptors and nerve-growth-factor-induced cell differentiation.

Authors:  J Meldolesi; G Gatti; A Ambrosini; T Pozzan; E W Westhead
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

7.  Second-messenger generation in PC12 cells. Interactions between cyclic AMP and Ca2+ signals.

Authors:  G Gatti; L Madeddu; A Pandiella; T Pozzan; J Meldolesi
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

8.  Interaction of forskolin with the effect of atropine on [3H]acetylcholine secretion in guinea-pig ileum myenteric plexus.

Authors:  P Alberts; V R Ogren
Journal:  J Physiol       Date:  1988-01       Impact factor: 5.182

9.  Forskolin mimics the hydrosmotic action of vasopressin in the urinary bladder of toads Bufo marinus.

Authors:  R C De Sousa; A Grosso
Journal:  J Physiol       Date:  1985-08       Impact factor: 5.182

10.  Forskolin: its effects on potassium-evoked release of vasopressin from the rat neurohypophysis.

Authors:  D Bowman; D B Hope
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.